Next Article in Journal
Glutathione Transferase (GST)-Activated Prodrugs
Next Article in Special Issue
Polysaccharide-Based Micelles for Drug Delivery
Previous Article in Journal
Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic
Previous Article in Special Issue
Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 5
Issue 1
10.3390/pharmaceutics5010201
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies

by
Chalet Tan
*,
Yingzhe Wang
and
Wei Fan
Cancer Nanomedicine Laboratory, Department of Pharmaceutical Sciences, Mercer University, Atlanta, GA 30341, USA
*
Author to whom correspondence should be addressed.
Pharmaceutics 2013, 5(1), 201-219; https://doi.org/10.3390/pharmaceutics5010201
Submission received: 21 December 2012 / Revised: 28 February 2013 / Accepted: 13 March 2013 / Published: 22 March 2013
(This article belongs to the Special Issue Micellar Drug Delivery)
Browse Figure
Versions Notes

Abstract

As versatile drug delivery systems, polymeric micelles have demonstrated particular strength in solubilizing hydrophobic anticancer drugs while eliminating the use of toxic organic solvents and surfactants. However, the true promise of polymeric micelles as drug carriers for cancer therapy resides in their potential ability to preferentially elevate drug exposure in the tumor and achieve enhanced anticancer efficacy, which still remains to be fully exploited. Here, we review various micellar constructs that exhibit the enhanced permeation and retention effect in the tumor, the targeting ligands that potentiate the anticancer efficacy of micellar drugs, and the polyplex micelle systems suitable for the delivery of plasmid DNA and small interference RNA. Together, these preclinical studies in animal models help us further explore polymeric micelles as emerging drug carriers for targeted cancer therapy.
Keywords: block polymer; EPR effect; tumor-targeting ligand; pharmacokinetics; targeted cancer therapy block polymer; EPR effect; tumor-targeting ligand; pharmacokinetics; targeted cancer therapy

Share and Cite

MDPI and ACS Style

Tan, C.; Wang, Y.; Fan, W. Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies. Pharmaceutics 2013, 5, 201-219. https://doi.org/10.3390/pharmaceutics5010201

AMA Style

Tan C, Wang Y, Fan W. Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies. Pharmaceutics. 2013; 5(1):201-219. https://doi.org/10.3390/pharmaceutics5010201

Chicago/Turabian Style

Tan, Chalet, Yingzhe Wang, and Wei Fan. 2013. "Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies" Pharmaceutics 5, no. 1: 201-219. https://doi.org/10.3390/pharmaceutics5010201

APA Style

Tan, C., Wang, Y., & Fan, W. (2013). Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies. Pharmaceutics, 5(1), 201-219. https://doi.org/10.3390/pharmaceutics5010201

Article Metrics

Back to TopTop